Carta Healthcare Expands AI Platform with Realyze Intelligence Acquisition
Slice of Healthcare Team
Dec 17, 2024
Key Highlights
- Carta Healthcare acquires Realyze Intelligence to enhance its AI capabilities and drive clinical trial matching.
- Realyze Intelligence's AI technology identifies patients for trials in seconds, improving oncology outcomes.
- Combined platforms reduce labor demands for clinical data abstraction and research while enhancing trial feasibility.
- UPMC Hillman Cancer Center saw 7x more patients matched to trials using Realyze Intelligence.
- Focus on cancer research addresses urgent global needs with advanced data automation and analysis.
Source: PR Newswire
Notable Quotes
“ We believe data is the single most important ingredient to improve healthcare. We are inspired by Realyze Intelligence’s shared ability to maximize insights from clinical data for clinical trials and cancer registries. ”
Brent Dover, CEO at Carta Healthcare
“ High-quality, timely data is essential for identifying eligible patients, yet much of it remains trapped in EHRs. We are excited to revolutionize clinical trial matching and improve outcomes with Carta Healthcare. ”
Aaron Brauser, Founder and CEO at Realyze Intelligence
-2e14ed90-63f5-4ce1-84fc-3fa9506b84be.png&w=3840&q=75)
